Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Page 3 of 3

Operator: We have reached the end of the question-and-answer session. I would now like to turn the call back over to Dr. James Breitmeyer for closing comments.

James Breitmeyer: Thank you, Rob. We appreciate everybody’s time and attention and the good questions this afternoon. We are looking forward to an exciting end of this year and first half of next year and look forward to staying in touch with you. So with that, thank you for your time and we will sign off.

Operator: This concludes today’s conference. You may disconnect your lines at this time, and we thank you for your participation.

Follow Oncternal Therapeutics Inc. (NASDAQ:ONCT)

Page 3 of 3